Business
DiaMedica Therapeutics to Report Fourth Quarter 2020 Financials and Provide a Business Update March 11, 2021
MINNEAPOLIS--(BUSINESS WIRE)-- DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments
About this update from Diamedica Therapeutics Inc.
[{"type":"text","content":" MINNEAPOLIS--(BUSINESS WIRE)--\nDiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that its fourth quarter 2020 financial results will be released after the markets close on Wednesday, March 10th. DiaMedica will host a live conference call on Thursday, March 11th at 7:00 AM Central Time to discuss its business update and financial results.\n\nConference Call details:\n\n\n\nDate:\n\n\n\n\nThursday, March 11, 2021\n\n\n\n\n\nTime:\n\n\n\n\n7:00 AM CT / 8:00 AM ET\n\n\n\n\n\nWeb access:\n\n\n\n\nhttps://event.on24.com/wcc/r/2948450/3CC8FC74172F3DEDB9258000144DA5E4\n\n\n\n\n\nDial In:\n\n\n\n\n(866) 393-4306 (domestic)\n\n\n\n\n\n\n\n(734) 385-2616 (international)\n\n\n\n\n\nConference ID:\n\n\n\n\n9297319\n\n\n\n\nInterested parties may access the conference call by dialing in or listening to the simultaneous webcast. Listeners should log on to the website or dial in 15 minutes prior to the call. The webcast will remain available for play back on our website, under investor events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until March 18, 2021, by dialing (855) 859-2056 (US Toll Free), (404) 537-3406 (International), replay passcode 9297319.\n\nAbout DiaMedica Therapeutics Inc.\n\nDiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases. To learn more about DiaMedica, please visit www.diamedica.com. \nView source version on businesswire.com: https://www.businesswire.com/news/home/20210303005714/en/\n\nScott Kellen\nChief Financial Officer\nPhone: (763) 496-5118\[email protected]\n\nSource: DiaMedica Therapeutics Inc.","length":5880,"tagName":"div"}]